GONZALO CECILIA 4
4 · Talon Therapeutics, Inc. · Filed Aug 17, 2012
Insider Transaction Report
Form 4
GONZALO CECILIA
Director
Transactions
- Conversion
Series A-3 Convertible Preferred Stock, $0.001 Par Value
2012-08-17$100.00/sh+54,000$5,400,000→ 81,000 total(indirect: See Footnotes)Exercise: $0.35From: 2012-08-17→ Common Stock (15,428,570 underlying) - Conversion
Right to Acquire Series A-3 Convertible Preferred Stock
2012-08-17−54,000→ 510,000 total(indirect: See Footnotes)Exercise: $100.00From: 2012-01-09→ Series A-3 Conv. Pref. Stock (54,000 underlying)
Footnotes (4)
- [F1]See Exhibit 99.1, Note 1.
- [F2]See Exhibit 99.1, Note 2.
- [F3]See Exhibit 99.1, Note 3.
- [F4]See Exhibit 99.1, Note 4.